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Pradesh, Nagaland, Mizoram and Manipur are present, which point toward a substantial HCV burden. [6] [7] [8] [9] Limited studies also indicate marked genotypic heterogeneity of HCV in the northeastern region, which is in stark contrast to the other parts of India. [2, 10, 11] With this background, we investigated the proportion of HCV infection in newly diagnosed CLD patients from Meghalaya. In addition, we determined the HCV genotypes and examined their relevance with respect to the clinicolaboratory presentation.
mAteRIAls And methods

Ethics
The study was approved by the Institutional Ethics Committee, vide letter no. NEIGR/IEC/2013/101. Informed written consent was procured from all the participants.
Study design and participants
We carried out a prospective study of 1-year duration from July 2015 to June 2016 in a medical college hospital from Meghalaya. Newly diagnosed CLD patients during that period were recruited consecutively. The diagnosis of CLD was on the basis of history, clinical examination and ultrasound and biochemical findings. History about amount and duration of alcohol abuse, if any, was taken. All the patients were screened for seropositivity of hepatitis B virus (HBV), HCV and human immunodeficiency virus (HIV). Those seropositive for HCV were further subjected to HCV RNA level estimation and HCV genotyping. They were also interviewed about history of transfusion of blood/blood products, procedures such as dental extraction, surgeries and dialysis and high-risk behaviours such as IDU, sexual promiscuity, sharing of blades/razors and tattooing to elucidate the mode of HCV transmission. Body mass index (BMI) was assessed as per the World Health Organization protocol. [12] 
Laboratory techniques
Statistical analysis
The statistical analyses were performed in SPSS 17.0 (Chicago, IL, USA). The categorical variables were tabulated as counts and percentages, along with 95% confidence intervals (CIs), whenever appropriate. The Kolmogorov-Smirnov test revealed non-Gaussian distribution of the continuous variables, and hence, they were expressed as median (maximum-minimum value). Comparison of continuous data across the HCV genotypes was performed by the non-parametric Kruskal-Wallis test by ranks, while categorical data were compared by Chi-square test (with Yates's correction). A two-sided P < 0.05 was set as the level of statistical significance in all the analyses.
Results
A total of 196 patients were newly diagnosed with CLD during the 1-year study period. Gender preponderance (165 males, 31 females) was seen. Of the 43 HCV-infected cases, four patients did not undergo HCV genotyping. Genotyping in the remaining 39 cases revealed that majority of them were infected by genotype 3 (48.7%, 95% CI: 33.9-63.8), followed by genotype 6 (30.8%, 95% CI: 18.6-46.6) and genotype 1 (20.5%, 95% CI: 10.8-35.5) [ Table 2 ]. Genotypes 2, 4 and 5 were not detected in our study.
Amongst the different risk factors, IDU was found to be the chief mode of HCV transmission in our patients (28/43) [ Table 3 ]. This was true irrespective of the detected HCV genotypes. History of transfusion of blood/blood-related products and tattooing was present in four and three patients, respectively, while only one patient (infected with genotype 1) had history of sexual promiscuity. Another patient (infected with genotype 1) had both IDU and tattoo exposure, whereas a patient (infected with genotype 6) had history consistent with blood-borne as well as sexual transmission. In eight patients (out of 43), the mode of transmission could not be ascertained.
The age and gender composition of the patients did not differ significantly (P > 0.05) according to the genotypes [ Table 4 ]. BMI values were also comparable amongst patients infected by the three genotypes. Relationship of the genotypes with laboratory parameters was studied too. However, none of the liver function tests (namely total bilirubin, AST, ALT and PT-INR) differed significantly (P > 0.05) across the three genotypes. Significant differences in Hb concentration and blood cell counts (WBC and platelets) were absent (P > 0.05) as well. Patients infected by genotype 1 appeared to have a higher viral load than those infected with genotype 6, to be followed by the ones infected with genotype 3. However, these differences did not assume statistical significance (P > 0.05).
dIscussIon
Our study provides an insight into the aetiology of CLD in patients from Meghalaya. More specifically, we provide insights into the burden of HCV and the distribution of its genotypes in newly diagnosed CLD patients from the region. Although most of the cases of CLD in our study were alcohol and HBV infection related, the proportion of HCV infection was considerable (~22%). It was substantially higher than that reported from nearby Dibrugarh in Northeast India (~11%) [13] and Kolkata in East India (~15%). [14] The HCV seroprevalence in our CLD patients was also higher than that in North India (~14%). [15] In reports from South India, an even higher seroprevalence of HCV (33%-43%) in CLD patients had been documented. [16, 17] Most of the HCV-infected patients in our study belonged to genotype 3 (~49%). This is in contrast to global data, according to which genotype 1 is the major variety worldwide. However, other studies from India have documented genotype 3 as the predominant HCV genotype that accounts for ~64% of the cases, followed by genotype 1 that constitutes ~26% of the cases. [2, 11] A very recent report by Patil et al. also found genotype 3 (68%) to be the most common and genotype 1 (32%) to be the next common genotype in HCV-infected cases from rural Maharashtra. [18] The other HCV genotypes were not detected in their study. However, surprisingly, in our study, genotype 6 was found to be the second common genotype (~31%), to be followed by genotype 1 (~20%). Although the cases of genotype 6 in India are mostly described from the northeastern states, [2, 11] such high preponderance as in our study has been to the best of our knowledge hitherto unreported. In fact, a recent study by Medhi et al. in a predominantly tribal population from Northeast India (Assam and Manipur) found genotype 4 to be the most common HCV genotype (~31%).
[10] Genotypes 3 (~20%) and 1 (~15%) also outranked genotype 6 in that study, with the latter detected in ~ 14% of the cases. [10] In contrast, no case of genotype 4 was detected in our study. Information about distribution of HCV genotype is of epidemiological value. It has important implications in relation to diversity of the circulating genotypes, sources, modes of transmission and monitoring changes in their pattern of distribution over a period of time. [19] [20] [21] There is a scarcity of literature on HCV genotype 6 as compared to the other genotypes. The high frequency of genotype 6 in our participants may be due to the geographical proximity and ethnic relatedness of Northeast India with the Southeast Asian nations. It is increasingly believed that this genotype has circulated, adapted and evolved in Southeast Asia for a long time. [22] Pybus et al. estimated that all genotype 6 infections had descended from a common ancestor around 1100-1350 years ago and that its distribution in Southeast Asia is characterised by substantial phylogeographic structure and two distinct phases of epidemic history before and during the 20 th century. [23] The risk factors of HCV transmission include blood and blood product transfusion, unsafe sexual practices, IDU and unsafe injection practices, tattooing and acupuncture. In our study, IDU was found to be the most common mode of HCV transmission. Intravenous and percutaneous drug abuse is a significant problem in the northeastern states. [24] This is often attributed to the proximity of the region to the infamous 'Golden Triangle' (Myanmar, Laos and Thailand), world's major hub of illicit drug production and trafficking. [24] Further, IDUs from Northeast India are at a high risk of contracting HCV infection due to unsafe injecting practices. [9] The genotype distribution did not appear to be influenced by the mode of transmission of the virus too. IDU was the major mode of transmission for all the detected genotypes. This is in contrast to the report by Medhi et al. where IDU was found to be the most common mode of transmission for genotype 4a, whereas exposure to multiple sexual partners and professional barbers were the major modes of transmission for genotypes 1a and 1c, respectively. [10] From a therapeutic perspective, however, the current treatment for HCV infection is pan-genotypic. Therefore, the need to determine HCV genotype except in difficult to treat patients is becoming obsolete.
conclusIons
This study contributes toward understanding the burden of HCV in newly diagnosed CLD patients. It also describes for the first time the diversity of HCV genotypes associated with CLD cases from Meghalaya. Genotype 3 was the most common HCV variant. Genotype 6 which was the next frequent HCV variant also had a substantial presence in our patients.
History of IDU exposure appeared to be the chief mode for HCV transmission.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
